CONTROLLING COST AND QUALITY IN POST-ACUTE CARE › wp-content › uploads › 2015 › 03 ›...
Transcript of CONTROLLING COST AND QUALITY IN POST-ACUTE CARE › wp-content › uploads › 2015 › 03 ›...
©2015 CHESS Proprietary and Confidential
CONTROLLING COST AND QUALITY IN POST-
ACUTE CARE Lisa P. Shock, MHS, PA-C Director of Care Transformation, CHESS Keith Thompson, MS, MA Data Scientist
©2015 CHESS Proprietary and Confidential 2
©2015 CHESS. All rights reserved. WARNING: This document/presentation is protected by federal copyright law and is provided for education on behalf of CHESS ONLY. Copying, reproduction, modification, distribution, display, or transmission of any portion of this document for any purpose is strictly prohibited without the express written consent of CHESS.
©2015 CHESS Proprietary and Confidential 3
• Defining the Post-Acute Care Management Mission and Purpose
• Clinical Outcomes and Drivers • Defining the Research Questions • Analytics Methodologies • Discussion of Data-Driven Clinical Change
OBJECTIVES
©2015 CHESS Proprietary and Confidential 4
• Defining the Post-Acute Care Management Mission and Purpose
• Clinical Outcomes and Drivers • Defining the Research Questions • Analytics Methodologies • Discussion of Data-Driven Clinical Change
OBJECTIVES
©2015 CHESS Proprietary and Confidential 5
“The health outcomes of a group of individuals, including the distribution of such outcomes within the group” - Kindig and Stoddart, 2003
POPULATION HEALTH
©2015 CHESS Proprietary and Confidential
POST ACUTE CARE NETWORK MANAGEMENT
©2015 CHESS Proprietary and Confidential
TRANSFORMATION IN REVENUE
7
Revenue from Pay for Value
Revenue from Fee-For-Service (FFS)
2013 2023
FFS FFV
Revenue from Fee for Service (FFS) and from Pay for Value as % of total provider revenue
PROVIDER REVENUE WILL BE PRIMARILY DRIVEN BY PAY FOR VALUE IN THE NEXT DECADE ….
... ACCORDING TO LEADING INDUSTRY OBSERVERS
National Commission on Physician Payment Reform called for a phase out of the FFS model within 5 years
Partnership for the Future of Medicare (PFM) believes the FFS
payment model should be phased out over the next 5-7 years
Harvard Business Review called for a shift from the volume and
profitability of services provided to the patient outcomes achieved
©2015 CHESS Proprietary and Confidential 8
• Defining the Post-Acute Care Management Mission and Purpose
• Clinical Outcomes and Drivers • Defining the Research Questions • Analytics Methodologies • Discussion of Data-Driven Clinical Change
OBJECTIVES
©2015 CHESS Proprietary and Confidential
Anecdotal
Patient satisfaction
Functional assessment and quality of life surveys
Patient engagement
Standard process and outcomes measures
Utilization and financial measures
MEASURING SUCCESS
©2015 CHESS Proprietary and Confidential
FACTORS DRIVING THE PUSH
10
Regulation
Healthcare Spend
Technology
Outcomes
•ACO •Medicare Advantage
•Pressure from employers •Pressure from consumers
•EHR adoption •HIE and interconnectivity
•US versus Western/OECD (Org for Economic Co-op and Dev) nations on various health indicators
MOVE FROM FFS TO FFV
©2015 CHESS Proprietary and Confidential
JAN 26, 2015
©2015 CHESS Proprietary and Confidential
CHESS CLIENT – CORNERSTONE Observed Medicare Expense
20%
60% 28%
Population Distribution Cost Distribution
28%
1.7%
70% 20%
©2015 CHESS Proprietary and Confidential
TOTAL COST OF CARE - CHC Cornerstone
35%
16% 15%
9% 6% 5% 4% 3% 3% 2% 2% 1% 0%
0%
5%
10%
15%
20%
25%
30%
35%
40%
©2015 CHESS Proprietary and Confidential
QUALITY AND POPULATION HEALTH
TIMELY
EQUITABLE
EFFECTIVE
EFFICIENT
SAFE
Quality Measures
and Utilization
Review
©2015 CHESS Proprietary and Confidential 15
• Defining the Post-Acute Care Management Mission and Purpose
• Clinical Outcomes and Drivers • Defining the Research Questions • Analytics Methodologies • Discussion of Data-Driven Clinical Change
OBJECTIVES
©2015 CHESS Proprietary and Confidential
WHICH FACILITIES?
Lowest readmit rate?
Lowest cost?
Fewest publicly reported (survey) deficiencies?
Relative to specific diagnoses?
©2015 CHESS Proprietary and Confidential
WHICH PATIENTS?
Highest medical cost?
Medication spend?
Most office visits?
Most ED visits?
Most hospitalizations?
Specific diagnoses?
©2015 CHESS Proprietary and Confidential 18
• Defining the Post-Acute Care Management Mission and Purpose
• Clinical Outcomes and Drivers • Defining the Research Questions • Analytics Methodologies • Discussion of Data-Driven Clinical Change
OBJECTIVES
©2015 CHESS Proprietary and Confidential 19
ANALYTICS TEAM • Generalist vs. Specialist • Generalist – subset of skills in 2 or more domains • Specialists – assembly line approach • 2:1 or 3:1 ratio of generalists to specialists
©2015 CHESS Proprietary and Confidential 20
TYPES OF ANALYTICS
Descriptive
Predictive
Prescriptive
©2015 CHESS Proprietary and Confidential 21
POST-ACUTE DASHBOARD
View Dashboard Demo Tableau
SQL
Visual Studio SSIS TOOLS
Python
©2015 CHESS Proprietary and Confidential 22
DEALING WITH (MISSING?) DATA
PROVNUM: 345115 BRIAN CTR HEALTH & REHAB/SALISBURY
635 STATESVILLE BOULEVARD SALISBURY, NC 28144
NPI: 1295856151 BRIAN CENTER HEALTH AND REHABILITATION – SALISBURY
635 STATESVILLE BLVD SALISBURY, NC 28144
SIMILARITY: 0.78 CONFIDENCE: 0.99 NAME SIMILARITY: 0.77 ADDRESS SIMILARITY: 0.80 CITY SIMILARITY: 1.0 ZIP CODE SIMILARITY: 1.0 CLASSIFICATION: MATCH
TRAIN DECISION TREE CLASSIFIER
©2015 CHESS Proprietary and Confidential 23
SIMPLE SNF SCORECARD 𝑋1 = 𝐿𝐿𝐿 = 30.2 𝑋2 = 𝐶𝐶𝐶𝐶 = 10658 𝑋3 = 𝑅𝑅𝑅𝑅𝑅𝑅𝐶𝐶 = 0.175 𝑋4 = 𝐸𝐸 𝑉𝑅𝐶𝑅𝐶𝐶 = 379 𝑋5 = 𝐸𝑅𝐷𝑅𝐷𝑅𝑅𝐷𝐷𝑅𝑅𝐶 = 13
Scale
𝑋𝑋1 = 𝐿𝐿𝐿 = 0.593 𝑋𝑋2 = 𝐶𝐶𝐶𝐶 = 0.350 𝑋𝑋3 = 𝑅𝑅𝑅𝑅𝑅𝑅𝐶𝐶 = 0.405 𝑋𝑋4 = 𝐸𝐸 𝑉𝑅𝐶𝑅𝐶𝐶 = 0.547 𝑋𝑋5 = 𝐸𝑅𝐷𝑅𝐷𝑅𝑅𝐷𝐷𝑅𝑅𝐶 = 0
Wei
ght
Score = 0.376 Rank = 7th
©2015 CHESS Proprietary and Confidential 24
TYPES OF ANALYTICS
Descriptive
Predictive
Prescriptive
©2015 CHESS Proprietary and Confidential 25
READMISSIONS LITERATURE
• Kansagara et al., 2011 - JAMA • Identified 30 studies who reported both training metrics and test validation metrics • C-statistics between 0.55 and 0.83
• Only 6 studies above 0.7 • 2 of these were for disease-specific models • Best performing model used survey / chart review data (e.g., functional status)
©2015 CHESS Proprietary and Confidential 26
PREDICTIVE MODELING
Goal: • Predict 30-day all cause readmissions for general patient population Variable Types: • Claims data – disease states / comorbidities, SNF readmit rates, DRG values • Clinical data – medication classes, demographics (will add lab values, vitals later) • Survey data – staff-to-patient ratios, deficiencies Missing data • Inferred missing (quality) values based on averages Types of Models Considered: • Logistic regression • Random forest
©2015 CHESS Proprietary and Confidential 27
LOGISTIC REGRESSION
Variable P-Value
CHF < 0.0001
Renal Disease < 0.0001
Readmit Rate < 0.0001
Peripheral Vascular Disease
0.008
Age 0.009
DRG Weight 0.009
Antipsychotic 0.031
IP Visit Count 0.033
Antidepressant 0.045 C-statistic (AUC) = 0.71 Sensitivity = 0.65 Specificity = 0.68 Precision = 0.33
©2015 CHESS Proprietary and Confidential 28
RANDOM FOREST
Charlson Score IP Visit Count ED Visit Count DRG Weight Readmit Rate
AUC = 0.67 Sensitivity = 0.66 Specificity = 0.61 Precision = 0.29
©2015 CHESS Proprietary and Confidential 29
ENSEMBLE CLASSIFIER
• Different models have different strengths and weaknesses • Ensemble classifiers can draw on the strengths of multiple approaches while mediating
the weaknesses
©2015 CHESS Proprietary and Confidential 30
TYPES OF ANALYTICS
Descriptive
Predictive
Prescriptive
©2015 CHESS Proprietary and Confidential 31
OUR GOAL
𝐸 𝐷𝐶𝐶𝐶 𝐶𝐷 𝑝𝑅𝐶𝑅𝑅𝐷𝐶 𝐴 𝐷𝑅𝐷𝑅𝑓𝑅𝐶𝑓 𝑋)
= 𝐿𝑆𝑆 𝑋 𝐷𝐶𝐶𝐶 + 𝑅𝐷𝑝𝑅𝐶𝑅𝑅𝐷𝐶 𝐷𝐶𝐶𝐶 𝑝 𝑟𝑅𝑅𝑅𝑅𝑅𝐶 𝐴,𝑋) + 𝐿𝑆𝑆 𝑋 𝐷𝐶𝐶𝐶 (1 − 𝑝 𝑟𝑅𝑅𝑅𝑅𝑅𝐶 𝐴,𝑋))
argmin𝑋
𝐸 𝐷𝐶𝐶𝐶 𝐶𝐷 𝑝𝑅𝐶𝑅𝑅𝐷𝐶 𝐴 𝐷𝑅𝐷𝑅𝑓𝑅𝐶𝑓 𝑋)
Choose:
Goal: Build stochastic models that allow us to estimate …
©2015 CHESS Proprietary and Confidential 32
NEXT STEPS • Add EMR data (labs, vitals, etc.)
• Lack of clinical data from inpatient and SNF setting
• Partnering with area hospitals • Partnering with area SNFs • Getting access to MDS / Oasis data
• Risk / case-mix adjustment for metrics
• Build disease-state specific models
• Play more with data
©2015 CHESS Proprietary and Confidential 33
• Defining the Post-Acute Care Management Mission and Purpose
• Defining the Research Questions • Clinical Outcomes and Drivers • Analytics • Discussion of Data-Driven Clinical Change
OBJECTIVES
©2015 CHESS Proprietary and Confidential 34 34 Proprietary and Confidential
Claims
Demographics
Clinical (EMR) Data
Quality Metrics
Risk Scoring
Patient Registries
Identify patients with health challenges
Intervene to support better outcomes
Measure success
Types of Data Using the Data for Transformation
USING DATA TO DRIVE RESULTS
©2015 CHESS Proprietary and Confidential
PREDICTIVE ANALYTICS AND RISK SCORING
Predictive analytics allows resources to
be targeted to prevent a health
crisis.
Risk
Sco
re
Diagnoses
Medications and Compliance
Recent care history
©2015 CHESS Proprietary and Confidential 36
CHESS CARE PARTNER RELATIONS
Consult & Understand
Execute Strategy
Develop Terms of
Engagement
Define Scope
Define Strategy Needs
Assessment
• Build? • Buy? • Collaborate?
©2015 CHESS Proprietary and Confidential 37
NETWORK MANAGEMENT
©2015 CHESS Proprietary and Confidential 38
NETWORK MANAGEMENT
©2015 CHESS Proprietary and Confidential 39
NETWORK MANAGEMENT
©2015 CHESS Proprietary and Confidential 40
• Must be committed to the Triple Aim • Agree to shared accountability for whole-
person care delivery • Agree to Continuous Quality Improvement • Agree to share data in usable formats
PREFERRED PROVIDERS - CHESS ACO
©2015 CHESS Proprietary and Confidential
THANK YOU!!!
• Not everything that counts can be measured
• Not everything that can be measured counts